TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis Biotech Investing
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial Pharmaceutical Investing
Avricore Health and Molecular You Announce Launch of myCannabisPGx Genetic Test for Safe Medical Cannabis Use Medical Device Investing
Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company Cannabis Investing News
Life Science Big News Roundup: NanoSphere and Stat Shield Technology Form Strategic Partnership; MediPharm Upgrades to the OTCQX Best Market Life Science Investing News
